Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.

PloS One
Scott R PlotkinVictor F Mautner

Abstract

Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis are at risk for multiple nerve sheath tumors and premature mortality. Traditional magnetic resonance imaging (MRI) has limited ability to assess disease burden accurately. The aim of this study was to establish an international cohort of patients with quantified whole-body internal tumor burden and to correlate tumor burden with clinical features of disease. We determined the number, volume, and distribution of internal nerve sheath tumors in patients using whole-body MRI (WBMRI) and three-dimensional computerized volumetry. We quantified the distribution of tumor volume across body regions and used unsupervised cluster analysis to group patients based on tumor distribution. We correlated the presence and volume of internal tumors with disease-related and demographic factors. WBMRI identified 1286 tumors in 145/247 patients (59%). Schwannomatosis patients had the highest prevalence of tumors (P = 0.03), but NF1 patients had the highest median tumor volume (P = 0.02). Tumor volume was unevenly distributed across body regions with overrepresentation of the head/neck and pelvis. Risk factors for internal nerve sheath tumors included decreasing numbers of café-au-lai...Continue Reading

Associated Clinical Trials

References

Jul 1, 1994·Nature Genetics·T JacksR A Weinberg
Dec 2, 1996·American Journal of Medical Genetics·L Dugoff, E Sujansky
May 16, 1997·American Journal of Medical Genetics·J M Friedman, P H Birch
Jan 8, 1998·Archives of Dermatology·V F MautnerJ Gottschalk
Jun 26, 1998·Calcified Tissue International·P Mac Namara, H C Loughrey
Dec 11, 1999·Science·K S VogelL F Parada
May 8, 2000·American Journal of Medical Genetics·D J WaggonerD H Gutmann
Apr 3, 2001·American Journal of Human Genetics·S A RasmussenJ M Friedman
Dec 11, 2002·Neurology·M E BaserD G R Evans
Feb 26, 2003·Genes & Development·Karen CichowskiTyler Jacks
Aug 22, 2003·Experimental Dermatology·Yasuhiro KawachiFujio Otsuka
Sep 10, 2003·Journal of Neurosurgery·Goro OtsukaJun Yoshida
Jun 11, 2004·American Journal of Human Genetics·Michael E BaserD Gareth R Evans
Jun 16, 2005·Neurology·M MacCollinE S Roach
Oct 17, 2007·International Journal of Technology Assessment in Health Care·Shoo Lee, Anthony Armson
Nov 1, 2007·British Journal of Cancer·M Curto, A I McClatchey
Jun 19, 2008·Neuro-oncology·Victor-F MautnerJan M Friedman
Apr 30, 2010·The Journal of Investigative Dermatology·Emilie SbidianUNKNOWN Members of NF France Network
May 6, 2011·Orphanet Journal of Rare Diseases·Tu Anh DuongPierre Wolkenstein
Jun 23, 2011·European Journal of Human Genetics : EJHG·D Gareth R EvansSusan M Huson

❮ Previous
Next ❯

Citations

Dec 25, 2012·Clinical Biochemistry·Miriam J SmithScott R Plotkin
Jun 1, 2014·Cancer Treatment Reviews·Stephanie Hui-Su LimPaul de Souza
Feb 22, 2013·Expert Opinion on Investigational Drugs·David H GutmannRoger J Packer
Nov 12, 2013·Neuroimaging Clinics of North America·Shivani AhlawatJaishri Blakely
Feb 13, 2013·American Journal of Medical Genetics. Part a·Scott R PlotkinMarco Giovannini
Mar 26, 2014·American Journal of Medical Genetics. Part a·Vanessa L MerkerScott R Plotkin
Apr 23, 2015·American Journal of Medical Genetics. Part a·Kimberly JettVictor F Mautner
Mar 21, 2017·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Natalie WinterAlexander Grimm
Jul 8, 2017·Journal of Neurosurgery·Daipayan GuhaGelareh Zadeh
Aug 14, 2013·Nature Reviews. Clinical Oncology·Andrew L Lin, David H Gutmann
May 23, 2020·Stomatologii︠a︡·M V KorolenkovaA A Basiev
Jul 28, 2016·Cancer Immunology, Immunotherapy : CII·Said FarschtschiAndreas Kurtz
Feb 1, 2018·Medicine·Justin T JordanScott R Plotkin
Oct 27, 2018·Frontiers in Cellular Neuroscience·Jo Anne StrattonJeff Biernaskie
Jul 1, 2020·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Yun MaFlorent Elefteriou
Apr 27, 2018·British Journal of Cancer·Robert J AllawayLu Q Le
Apr 27, 2018·The Journal of Dermatology·Yuichi YoshidaOsamu Yamamoto
Sep 8, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Magdalena KoczkowskaLudwine M Messiaen
Feb 8, 2019·JCI Insight·Jonathan S FletcherNancy Ratner
Jan 27, 2019·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Ravi V GottumukkalaMary-Louise C Greer
Jul 18, 2020·Proceedings·Aaminah F AzharJonathan R Hinshelwood
Jul 10, 2020·Neuro-oncology Advances·Alexander PemovDavid T Miller
Jun 12, 2020·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Eloïse Baudou, Yves Chaix
Jun 13, 2020·Acta neurochirurgica·Courtney PendletonChristopher J Klein
Feb 19, 2017·Human Genetics·Hildegard Kehrer-SawatzkiDavid N Cooper

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception

Software Mentioned

R
SAS

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

© 2021 Meta ULC. All rights reserved